Company Name: Neo Medical Pharmaceuticals Co., Ltd.
Established: 2003
Toothpaste Manufacturing License (Quasi-drug): Obtained in 2023
Business Areas: Toothpaste and quasi-drug manufacturing, pharmacy distribution, export business

Neo Medical Pharmaceuticals was founded in 2003, and in 2023, we officially obtained a toothpaste manufacturing license (quasi-drug) from the Ministry of Food and Drug Safety (MFDS) of Korea.

With our own certified production facility in Goyang, we manufacture a wide range of quasi-drug products including toothpaste, oral rinses, hand sanitizers, and medical bandages.

Our core brand, the "NeoCare" toothpaste series, has been sold exclusively through pharmacies for over 12 years, becoming one of Korea's most beloved oral care products.

We are actively expanding into global markets through OEM, ODM, and OBM partnerships, and aim to be a trusted K-healthcare brand on the international stage.

We are certified with ISO 9001 (Quality Management), ISO 14001 (Environmental Management), and ISO 45001 (Occupational Health & Safety Management),
ensuring consistent quality, regulatory compliance, and safe manufacturing operations.

Neo Medical Pharmaceuticals is committed to providing high-quality, effective, and safe quasi-drug solutions to both domestic and global customers.

Neo Gum Care Toothpaste is specially formulated for weakened gums and has been sold in Korean pharmacies for 12 years.
The series includes White Care, Sensitivity Care, and Bad Breath Care.
All products are directly supplied to pharmacies nationwide by Neo Medical’s headquarters.